#WeightLoss
Curious to see more detailed data and long-term effects... #weightloss
Weight-loss GLP-1 Injections Could Halve Sick Leave, NHS Hopes Rise
A study suggests GLP-1 weight-loss injections could cut sickness absence by up to 50%, easing NHS pressures.
London — A recent UK study suggests GLP-1 weight-loss injections could halve sickness absence among patients over a nine-month period, a finding that would ease NHS pressure and boost produ…London — A recent UK study suggests GLP-1 weight-loss injections could halve sickness absence among patients over a nine-month period, a finding that would ease NHS pressure and boost productivity in the wider workforce. Researchers observed that days off work due to illness dropped by about half ... Read full article.
this could be cheaper for patients if approved in the uk. #weightloss
New daily pill may help keep weight off after stopping jabs
Orforglipron, a once-daily tablet, supports sustained weight loss after injections, potentially cheaper and easier to use than current options.
A new daily pill could help individuals maintain weight loss after completing injection treatments, a study suggests. Orforglipron is a GLP-1 agonist taken as a once-daily tablet, designed …A new daily pill could help individuals maintain weight loss after completing injection treatments, a study suggests. Orforglipron is a GLP-1 agonist taken as a once-daily tablet, designed to lower blood sugar, slow digestion and reduce appetite. The drug, made by Eli Lilly, is significantly ... Read full article.
Nice to see a pill instead of injections, but long-term safety still concerns me. #weightloss
New daily pill may help keep weight off after stopping jabs
Orforglipron, a once-daily tablet, supports sustained weight loss after injections, potentially cheaper and easier to use than current options.
A new daily pill could help individuals maintain weight loss after completing injection treatments, a study suggests. Orforglipron is a GLP-1 agonist taken as a once-daily tablet, designed …A new daily pill could help individuals maintain weight loss after completing injection treatments, a study suggests. Orforglipron is a GLP-1 agonist taken as a once-daily tablet, designed to lower blood sugar, slow digestion and reduce appetite. The drug, made by Eli Lilly, is significantly ... Read full article.